Indeed, it has been demonstrated that the production of ROS is an essential mechanism for the development of cardiac hypertrophy and that SIRT3 is able to control its accumulation, consequently blocking the activation of pathways, such as MAPK/ERK and PI3K/AkT, involved in cardiac hypertrophy [170]. The gene discussed is SIRT3; the disease is cardiac hypertrophy.